<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02423135</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol 06/14</org_study_id>
    <secondary_id>12C14NL</secondary_id>
    <nct_id>NCT02423135</nct_id>
  </id_info>
  <brief_title>Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping</brief_title>
  <official_title>Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion Using a Combination of Multiple Biomarkers in Different Matrices.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the proposed project is to perform a clinical study in which volunteers will
      receive autologous blood transfusions in DEHP-free blood bags.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of blood parameters profile, iron metabolism and genomic compounds</measure>
    <time_frame>1 month</time_frame>
    <description>Blood profiling such as measurement of concentration of different blood cells and hemoglobin will be measured up to 15 days after blood-reinfusion. Concentration of free-iron, ferritin and hepcidin will be measured in plasma and serum up to 15 days after blood re-infusion.
Concentration of circulating microRNAs will be measured in plasma also up to 15 days after blood re-infusion. All measures are compared.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Transfusion Reaction</condition>
  <arm_group>
    <arm_group_label>Blood bags without DEHP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention : Autologous blood transfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood bags with DEHP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention : Autologous blood transfusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous blood transfusion</intervention_name>
    <description>Volunteers make a blood donation and after 36 days of storage this blood is re-infused in the same volunteers.</description>
    <arm_group_label>Blood bags without DEHP</arm_group_label>
    <arm_group_label>Blood bags with DEHP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have to fill the swiss blood donation formulary

        Exclusion Criteria:

          -  Anemia

          -  Cardiovascular disease

          -  Neurologic disease

          -  Not performed a blood donation for 5 weeks ago the start of the study.

          -  Immunological disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Leuenberger, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swiss Laboratory for Doping Analyses</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Swiss Laboratory for Doping Analyses</name>
      <address>
        <city>Epalinges</city>
        <state>Vaud</state>
        <zip>1066</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2014</study_first_submitted>
  <study_first_submitted_qc>April 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>April 17, 2015</last_update_submitted>
  <last_update_submitted_qc>April 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Nicolas Leuenberger</investigator_full_name>
    <investigator_title>Dr, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Transfusion Reaction</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 23, 2015</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>September 28, 2015</submitted>
    <returned>October 28, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

